Search Results for: PEP for non occupational HIV exposure

Selecting and Initiating a 28-Day Course of PEP

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 RECOMMENDATIONS Considerations and Caveats Suspected seroconversion: If acute HIV infection is suspected at any time, immediate consultation with a clinician experienced in managing acute HIV infection is advised (see the NYSDOH AI guideline Diagnosis and Management of Acute HIV). Clinicians can call the … Continue reading “Selecting and Initiating a 28-Day Course of PEP”

Source HIV Status and Management

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 In many cases of non-occupational exposure, the source is not available for testing. The HIV status of the source should not be the focus of the initial evaluation; determination of whether the exposure warrants PEP and, when indicated, prompt initiation of PEP, … Continue reading “Source HIV Status and Management”

Exposure Risk Evaluation

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 RECOMMENDATIONS Box 3: Risk of HIV Transmission From a Source With HIV Meaningful risk of transmission: Blood Semen Vaginal secretions Breast milk Cerebrospinal, synovial, pleural, peritoneal, pericardial, and amniotic fluids No meaningful risk of transmission: Nonbloody saliva Tears Sweat Nonbloody urine Nonbloody … Continue reading “Exposure Risk Evaluation”

First Dose of PEP and Management of the Exposure Site

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 RECOMMENDATIONS Exposure to HIV Is an Emergency An HIV exposure is a medical emergency and rapid initiation of PEP—ideally within 2 hours and no later than 72 hours post exposure—is essential to prevent infection. Therefore, this Committee encourages emergency departments, outpatient clinics, … Continue reading “First Dose of PEP and Management of the Exposure Site”

Rationale for PEP and Evidence of PEP Effectiveness

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 PEP in children material: Aracelis Fernandez, MD, with Lisa-Gaye Robinson, MD, and Ruby Fayorsey, MD Post-exposure prophylaxis (PEP) has been established to effectively prevent HIV infection in an exposed individual when initiated within 2 hours (ideal) and no later than 72 hours … Continue reading “Rationale for PEP and Evidence of PEP Effectiveness”

Exposure Risk in Children

Lead authors: Aracelis Fernandez, MD, with Lisa-Gaye Robinson, MD, and Ruby Fayorsey, MD, with the Medical Care Criteria Committee; June 2020 Although there is evidence to support HIV prophylaxis for perinatal exposure, there are no randomized clinical trials of PEP in children beyond the perinatal period. Types of exposures that may be reported in children include sexual … Continue reading “Exposure Risk in Children”

Sexual Assault Exposure Risk

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 Statistics on sexual assault in the United States show high rates of attempted or completed rape among several populations, including cisgender women, men, children, and transgender individuals: 21.3% of women reported attempted or completed rape* in their lifetime, with the first assault … Continue reading “Sexual Assault Exposure Risk”

Non-Occupational Exposure Risk

Lead author: Elliot DeHaan, MD, with the Medical Care Criteria Committee; November 2021 Box 1: Risk per 10,000 Exposures of Acquiring HIV From an Infected Source and Factors That Increase Risk Modified from the Centers for Disease Control and Prevention [CDC 2015]. Parenteral Exposure Risk: Needle sharing during injection drug use: 63 Percutaneous (needlestick): 23 … Continue reading “Non-Occupational Exposure Risk”

Q/A: HIV Testing

Download Q&A PDF Lead authors: Aisha Khan, DO, and Christine Kerr, MD, updated March 2019 Who Should be Tested for HIV? What does the NYSDOH AIDS Institute guideline recommend for HIV screening in the general population? Healthcare providers should offer HIV testing to all individuals aged >13 years as part of routine healthcare. What does NYS … Continue reading “Q/A: HIV Testing”

Partner Exposure to HIV and HPV

Medical Care Criteria Committee, July 2018 NEW YORK STATE REQUIREMENT AND RECOMMENDATION Treatment of lesions solely for the prevention of future transmission cannot be recommended because the value of treatment in reducing infectivity is not known. However, sex partners of patients who have genital lesions might benefit from counseling and examination to assess the presence … Continue reading “Partner Exposure to HIV and HPV”